CSBio Blog News and Resources for Peptides, Synthesis, and Purification

News

The President of the United States recently visited the Centers for Disease Control and Prevention (CDC), focused on the control of the spread of Covid-19. Speaking in a lab at the CDC, CSBio's peptide synthesizers can be seen behind the President and team.

With the release of CSBio's novel oligonucleotide synthesizers that allow for batch synthesis and optimized for polystyrene resin, CSBio has partnered with Sun Resin to specifically develop an optimized polystyrene resin for commercial scale oligonucleotide synthesis.

In this case study, we talk about CSBio's peptide synthesizer platform and knowledge that allows companies to utilize our peptide synthesizers during the early days of drug discovery, all way through commerical scale manufacturing